Journal
NMR IN BIOMEDICINE
Volume 21, Issue 10, Pages 1102-1111Publisher
WILEY
DOI: 10.1002/nbm.1287
Keywords
T-1 mapping; cardiac MRI; mouse; heart; manganese; calcium; myocardial infarction
Ask authors/readers for more resources
Manganese hits been used as a T-1-weighted MRI contrast agent in a variety of applications. Because manganese ions (Ma(2+)) enter viable myocardial cells via voltage-gated Ca2+ channels, manganese-enhanced MRI is sensitive to the viability and inotropic state of the heart. In spite of the established importance of Ca2+ revelation in the heart both before and after myocardial injury. monitoring strategies to assess Ca2+ homeostasis in affected cardiac tissues tare limited. This study implements a T-1-mapping method to obtain quantitative information both dynamically and over a range of MnCl2 infusion closes. To optimize the current Mn2+ infusion protocols, WC performed both close-dependent and temporal washout studies. A non-linear relationship between infused MnCl2 solution close and increase in left ventricular wall relaxation rate (Delta R-1) Was observed. Control mice also exhibited significant Mn2+ clearance over time. with et decrease in Delta R-1 of similar to 50% occurring in just 2.5 h. The complicated efflux time dependence possibly suggests multiple efflux mechanisms. With the use of the measured relationship between infused Mn2+ dose. Delta R-1, and inductively coupled plasma mass Spectrometry data analysis provided a means of estimating the absolute heart Mn concentration in giro. We show that this technique has the sensitivity to observe or monitor potential alterations in Ca2+ handling in vivo because of the physiological remodeling after myocardial infarction. Left ventricular free wall Delta R-1 values Were significantly lower (P=0.005) in the adjacent zone. surrounding the injured myocardial tissue, than in healthy tissue. This inferred reduction in Mn concentration can be used to estimate potentially salvageable myocardium in vivo for future treatment or evaluation of disease progression. Copyright (c) 2008 John Wiley & Sons. Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available